Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018.
The antimicrobial resistance landscape of Neisseria gonorrhoeae in New Zealand from November 2018 to March 2019 and the role of sexual orientation in transmission.
Mutations in parC contribute to resistance to ciprofloxacin.
Differences in antimicrobial resistance between exoU and exoS isolates of Pseudomonas aeruginosa.
Mutations in parC were associated with fluoroquinolone resistance.
Mutations in ParC correlate with fluoroquinolone resistance
Susceptibility of Neisseria gonorrhoeae to Zoliflodacin and Quinolones in Hyogo Prefecture, Japan.
associated with high non-susceptibility to quinolones
In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance.
Mutations in the parC gene were identified in mutants with elevated delafloxacin MICs.
Meningococcal Quinolone Resistance Originated from Several Commensal Neisseria Species.
Mutations in ParC, such as D86N, S87I, S87R, and E91G, contribute to quinolone resistance in N. meningitidis.
Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
Emergence of Carbapenem-resistant Clinical Isolates of Providencia Species.
Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
parC
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research